Worlds apart? A comparison of the new product development strategies of biopharmaceutical firms in Europe and the USA. Industry and Innovation.
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how the...
Saved in:
Main Authors: | , |
---|---|
Format: | Default Article |
Published: |
2009
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/14653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|